BioSpace News Archive

Alloy Therapeutics, a biotechnology ecosystem company, welcomes Trier Bryant as President of 82VS, Alloy’s affiliated venture studio.

Inscopix, Inc. announced that Kunal Ghosh, PhD, Chief Executive Officer of Inscopix, has been named to the PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry.

SimBioSys, a technology company developing a first of its kind precision medicine platform, combining biophysical modeling and artificial intelligence, announced the appointment of Anant Madabhushi, PhD and Donald Berry, PhD to its scientific advisory board.

Cellworks Group, Inc., a world leader in Genomic Biosimulation Services for Precision Pharma and Personalized Oncology, announced it has won The Challengers Innovative Business of the Year Award.

Adaptive Phage Therapeutics, Inc. announced “The AMR RAPID™ Challenge” at the World AMR Congress.

Curis, Inc. announced that James Dentzer, President and Chief Executive Officer of Curis, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 at 4:00 p.m. ET in New York, NY.

Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion technology, announced the appointment of James Reinstein as President and Chief Executive Officer.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT).

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, today announced that the U.S. Food and Drug Administration (FDA) has authorized a clinical trial of EDG-5506 in children with DMD.

RenovoRx, Inc. announced management’s participation in the upcoming H.C. Wainwright 24th Annual Global Investment Conference.